Carregant...
Overcoming Challenges for CD3-Bispecific Antibody Therapy in Solid Tumors
SIMPLE SUMMARY: CD3-bispecific antibody therapy is a form of immunotherapy that enables soldier cells of the immune system to recognize and kill tumor cells. This type of therapy is currently successfully used in the clinic to treat tumors in the blood and is under investigation for tumors in our or...
Guardat en:
| Publicat a: | Cancers (Basel) |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7829968/ https://ncbi.nlm.nih.gov/pubmed/33466732 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13020287 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|